|
|
| (11) | Number of the document | C 2064228 |
| (68) | Number of the document | 2064228 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 522 |
| (22) | Date of filing the application | 2022-10-24 |
| (41) | Date of publication of the application | 2022-11-10 |
| Date of publication of SPC | 2025-03-10 | |
| (24) | Date of coming into effect of SPC | 2027-11-13 |
| (71) |
Cara Therapeutics, Inc. ,
4 Stamford Plaza, 107 Elm Street, 9th floor, Stamford, CT 06902,
US
|
| (73) |
Vifor Fresenius Medical Care Renal Pharma Ltd,
Rechenstrasse 37, 9014 St. Gallen,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/22/1643, 2022-04-25 |
| (94) | 2032-11-12 |
| (95) | Difelikefalinas, bet kokia forma, kuriai taikoma pagrindinio patento apsauga |
| SPC granted |